Treatment of Nontuberculous Mycobacterial Pulmonary Disease - Guideline Learning Activities - Guideline Central

Treatment of Nontuberculous Mycobacterial Pulmonary Disease

American Thoracic SocietyEuropean Respiratory SocietyInfectious Diseases Society of America

Publication Date: July 6, 2020

The Treatment of Nontuberculous Mycobacterial Pulmonary Disease guideline, developed by the American Thoracic Society, European Respiratory Society, and Infectious Diseases Society of America, provides evidence-based recommendations for the treatment of pulmonary disease in adults (without cystic fibrosis or HIV infection) caused by the most common NTM pathogens.
13
Questions
36
Minutes Est.
260
Possible Points
Hard
Difficulty
Objectives
  • Identifying medication regimens for NTM pulmonary disease
  • Understanding the recommended duration of treatment for NTM pulmonary disease
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.